Elizabeth A. Olek
Director Técnico/Científico/I+D en KRONOS BIO, INC. .
Fortuna: 189 410 $ al 30/04/2024
Cargos activos de Elizabeth A. Olek
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| KRONOS BIO, INC. | Director Técnico/Científico/I+D | - | - |
| Corporate Officer/Principal | 01/02/2022 | - |
Historial de carrera de Elizabeth A. Olek
Antiguos cargos conocidos de Elizabeth A. Olek.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| LOXO ONCOLOGY INC | Corporate Officer/Principal | 01/01/2019 | 01/02/2022 |
| ACHILLION PHARMACEUTICALS, INC. | Director Técnico/Científico/I+D | 03/12/2007 | 18/06/2012 |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Corporate Officer/Principal | 01/01/2005 | 01/11/2007 |
| INTERMUNE INC | Director Técnico/Científico/I+D | 01/01/2003 | 01/07/2004 |
Genetics Institute LLC
 Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | Director Técnico/Científico/I+D | 01/09/1998 | 01/12/2002 |
Wyeth Research
 Wyeth Research Miscellaneous Commercial ServicesCommercial Services Part of Pfizer Inc., Wyeth Research discovers and develops platforms encompassing pharmaceuticals. The company is based in Cambridge, MA. | Director Técnico/Científico/I+D | 01/09/1998 | 01/12/2002 |
Formación de Elizabeth A. Olek.
| Boston University | Graduate Degree |
| University of the Sciences in Philadelphia | Undergraduate Degree |
| Philadelphia College of Osteopathic Medicine | Doctorate Degree |
Estadísticas
Internacional
| Estados Unidos | 11 |
Operativa
| Chief Tech/Sci/R&D Officer | 5 |
| Corporate Officer/Principal | 3 |
| Graduate Degree | 1 |
Sectorial
| Health Technology | 7 |
| Consumer Services | 4 |
| Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| KRONOS BIO, INC. | Health Technology |
| Empresas privadas | 6 |
|---|---|
Achillion Pharmaceuticals, Inc.
 Achillion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Achillion Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of oral small molecule complement system inhibitors. Its pipeline includes Danicopan and ACH-5228. The company was founded on August 17, 1998 and is headquartered in Blue Bell, PA. | Health Technology |
InterMune, Inc.
 InterMune, Inc. BiotechnologyHealth Technology InterMune, Inc. operates as a biotechnology company that researches, develops and commercializes therapies in pulmonology and orphan fibrotic diseases. It focuses on therapies for the treatment of idiopathic pulmonary fibrosis, a progressive and fatal lung disease. The firms research programs are focused on the discovery of targeted, small-molecule therapeutics and biomarkers to treat and monitor serious pulmonary and fibrotic diseases. The company was founded in 1998 and is headquartered in South San Francisco, CA. | Health Technology |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | Health Technology |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
Wyeth Research
Wyeth Research Miscellaneous Commercial ServicesCommercial Services Part of Pfizer Inc., Wyeth Research discovers and develops platforms encompassing pharmaceuticals. The company is based in Cambridge, MA. | Commercial Services |
Loxo Oncology, Inc.
 Loxo Oncology, Inc. Pharmaceuticals: MajorHealth Technology Loxo Oncology, Inc. is a biopharmaceutical company, which engages in the development of small molecule therapeutics for the treatment of cancer. It focuses on genetic alterations, targeted therapies, and genetic testing. The company was founded by Joshua H. Bilenker in May 2013 and is headquartered in Stamford, CT. | Health Technology |
- Bolsa de valores
- Insiders
- Elizabeth A. Olek
- Experiencia
